Home » The Netherlands

The Netherlands

Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND

Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …

Read more

Side Event: Ending Inequalities for People who Use Drugs: How the Global HIV Response can Transform Drug Policy (and vice versa)

Organized by the Medecins du monde with the support of Australia, the Netherlands, and the International Network of People who Use Drugs, the UNAIDS and the UNODC HIV/AIDS Section   The new Global AIDS Strategy and 2021 Political Declaration on HIV and AIDS include bold new targets on ‘social enablers’ and community involvement which can …

Read more

Plenary Item 7. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem

Chair: The commission has before it conference room paper ECN 720 21 (?) and note by the Secretariat of interagency cooperation and coordination of efforts in addressing and countering the world drug problem. Pursuant to commission resolution 51/14 relevant decisions of UNAIDS are transmitted to the Commission in a note by the Secretariat on promoting …

Read more

Side event: Strategic importance of real-time drug data

Organized by the UNODC Research and Trend Analysis Branch with the support of the Group of Friends of UNODC Research H.E. Stephan Klement, Ambassador, European Union Delegation: The EU particularly focuses on real time information. The new drug strategy of 2021-2025 acknowledges the need to addressing existing and evolving challenges of the drug situation, given the …

Read more